Obesity

Mga Pangunahing Punto

• Ang obesity ay chronic na pag-ipon ng sobrang adipose mula sa tuloy-tuloy na positive energy balance at isang excess-malnutrition state.
• Hinuhubog ang panganib ng behavior, genetics, medication at illness burden, sleep dysregulation, at social determinants of health.
• Pangunahing screening tools ang BMI at waist circumference, ngunit maaaring hindi makita ng BMI lamang ang body-composition at ethnicity-specific risk.
• Kabilang sa nursing priorities ang individualized assessment, realistic behavior-change goals, psychosocial support, at long-term adherence coaching.
• Kabilang sa treatment pathways ang lifestyle intervention, piling anti-obesity medications, at bariatric surgery para sa kwalipikadong high-risk profiles.
• Pinapataas ng obesity ang asthma-risk burden sa pamamagitan ng inflammatory signaling at airway hyperresponsiveness, at maaaring magpalala ng dyspnea sa pamamagitan ng pagbawas sa chest-wall at lung compliance.

Pathophysiology

Nabubuo ang obesity kapag patuloy na mas mataas ang caloric intake kaysa energy expenditure. Ang sobrang glucose at iba pang substrates ay kino-convert sa glycogen at fatty acids, pagkatapos ay iniimbak sa adipose tissue. Sa paglipas ng panahon, itinataguyod nito ang progresibong adiposity at cardiometabolic risk.

Kasangkot sa central appetite at satiety signaling ang hypothalamic pathways at hormones tulad ng leptin at ghrelin. Ang sleep disruption, chronic stress, at sedentary behavior ay maaaring ilipat ang pathways na ito tungo sa mas mataas na gutom at nabawasang satiety, na nagpapalakas ng overeating patterns. Maaari ring baguhin ng obesity ang pulmonary mechanics. Ang tumaas na chest-wall load ay nagpapababa sa respiratory compliance at nagpapataas ng work of breathing, habang ang inflammatory dietary patterns (high-fat, high-sugar, low nutrient density) ay maaaring magpalala ng airway reactivity, lalo na sa mga batang may asthma-risk phenotypes.

Classification

• BMI pattern: Karaniwang BMI >=30 ang obesity; karaniwang BMI >=40 ang severe obesity.
• Class pattern: Class I 30-34.9, class II 35-39.9, class III >=40.
• Ethnicity-adjusted pattern: Sa maraming Asian at South Asian populations, mas mababa ang risk thresholds (overweight 23-24.9, obesity >=25).
• Central-adiposity pattern: Nagdadagdag ng high-risk information ang waist circumference (karaniwang >40 inches sa males at >35 inches sa females).

Nursing Assessment

Pokus sa NCLEX

Unahin ang obesity-related risk clustering at kahandaan para sa sustained change, hindi lamang short-term weight targets.

• Suriin ang weight history, nakaraang weight-loss attempts, sleep pattern, physical-activity level, eating pattern, at psychosocial stressors.
• Suriin ang social determinants na nakaaapekto sa access sa nutrition at activity, kabilang ang affordability, community safety, at support systems.
• Sukatin at i-trend ang height, weight, BMI, at waist circumference gamit ang consistent technique.
• Suriin ang obesity-related comorbid patterns, kabilang ang hypertension, diabetes, dyslipidemia, sleep apnea, mood symptoms, at mobility limits.
• Suriin ang pulmonary overlap patterns (dyspnea, wheeze, exercise intolerance, at asthma-control burden) kapag kasabay ng respiratory disease ang obesity.
• Suriin ang medication at illness contributors na maaaring magpataas ng timbang.
• Suportahan ang diagnostics na inutos para sa risk-stratification (halimbawa metabolic panel, lipid profile, hemoglobin A1c, thyroid studies, liver/kidney studies, at sleep-study referral kapag naaangkop).

Nursing Interventions

• Gumamit ng collaborative at realistic goals na may staged lifestyle change sa halip na mabilis na hindi napapanatiling targets.
• Palakasin ang nutrition strategies: portion control, meal scheduling, lower-calorie substitutions, at food-diary tracking.
• Itaguyod ang activity plans na nakaangkop sa function at comorbidity status, na may progression sa paglipas ng panahon.
• Sa obesity na may asthma o chronic dyspnea, ipares ang weight-management counseling sa pulmonary-symptom tracking at anti-inflammatory food-pattern coaching.
• Gumamit ng motivational interviewing at nonstigmatizing language upang suportahan ang adherence at self-efficacy.
• I-coordinate ang interdisciplinary care kasama ang dietitian, behavioral-health support, endocrinology, at bariatric team kapag naaangkop.
• Muling suriin ang outcomes sa mga takdang pagitan at baguhin ang care plan kapag may lumitaw na adherence barriers o adverse effects.

Bariatric Surgery Considerations

• Karaniwang kandidato ang may BMI >=40 o BMI >=35 na may makabuluhang obesity-related comorbidity.
• Kabilang sa karaniwang procedures ang vertical sleeve gastrectomy at Roux-en-Y gastric bypass.
• I-monitor ang postoperative complications at deficiencies (halimbawa reflux, stricture, ulcer risk sa NSAID/smoking exposure, dumping syndrome, steatorrhea, at vitamin/mineral deficits).
• Palakasin ang lifelong follow-up, supplement adherence, at symptom escalation para sa dehydration, hypoglycemia, o severe GI intolerance.

Panganib ng Stigma at Adherence

Ang weight-focused judgment ay maaaring magpababa ng tiwala at follow-up adherence; gumamit ng person-centered counseling at shared goal setting.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
lipase-inhibitors(lipase inhibitors)	Orlistat	Ituro ang fat-distribution strategy, GI-effect management, at timing ng fat-soluble vitamins.
[anorexiants]	Phentermine, phentermine-topiramate	I-screen ang cardiovascular, mood, seizure, at pregnancy-related contraindications bago at habang therapy.
bupropion-naltrexone-for-weight-management(bupropion-naltrexone para sa weight management)	Naltrexone-bupropion ER	I-monitor ang neuropsychiatric symptoms, BP, seizure risk, at trend ng hypoglycemia sa diabetes.
non-insulin-injectable-diabetes-drugs(non-insulin injectable diabetes drugs)	Liraglutide, semaglutide	I-monitor ang GI tolerance at pancreatitis risk; iwasan ang hindi angkop na duplicate GLP-1 pathway use.
Melanocortin-pathway therapy	Setmelanotide	Gamitin lamang sa piling genetic-obesity pathways na may specialist-directed criteria.

Clinical Judgment Application

Clinical Scenario

Ang pasyenteng may BMI 38, hypertension, at type 2 diabetes ay nag-ulat ng mahinang tulog, mababang activity, at paulit-ulit na panandaliang diet attempts.

• Recognize Cues: Severe obesity na may cardiometabolic comorbidity at adherence barriers.
• Analyze Cues: Ang panganib ay itinutulak ng magkakumpol na physiologic at behavioral factors, hindi ng isang hiwalay na gawi lamang.
• Prioritize Hypotheses: Ang sustained lifestyle support na may comorbidity-safe pharmacologic planning ang agarang prayoridad.
• Generate Solutions: Bumuo ng staged nutrition/activity goals, magdagdag ng structured follow-up, at i-coordinate ang obesity-medication evaluation.
• Take Action: Simulan ang interdisciplinary plan, palakasin ang self-monitoring tools, at i-escalate para sa medication/surgical candidacy review kapag naaangkop.
• Evaluate Outcomes: Bumubuti ang weight trend, activity tolerance, at metabolic markers sa sustained adherence.

Related Concepts

• nutritional assessment framework - Pangunahing workflow para sa intake, anthropometric, at risk-cluster assessment.
• mga kondisyong nagdudulot ng imbalanced nutritional status - Konteksto ng excess-malnutrition at cardiometabolic risk clustering.
• anorexiants - Sympathomimetic anti-obesity pharmacotherapy pathway.
• lipase inhibitors - Nonstimulant anti-obesity medication pathway.
• metabolic syndrome at panganib ng adult chronic disease - High-risk cluster na madalas kasabay ng obesity.